Objective: To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is an Equity - Sector - Healthcare fund. The fund was launched inJul 12, 2018. Its risk level is . The NAV of the fund as onJul 04, 2025 is ₹40.07. Its expense ratio is 2.06 %. The fund has an AUM of ₹5,507.52 Cr.The fund is managed byDharmesh Kakkad,Sharmila D’mello.
The minimum initial investment is ₹5000 in Lumpsum mode.